Screening of Hub Genes Associated with Prognosis in Non-small Cell Lung Cancer by Integrated Bioinformatics Analysis

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2022 Feb 4

PMID 35117319

Authors

Yu Zeng

Nanhong Li

Riken Chen

Wang Liu

Tao Chen

Jinru Zhu

Mingqing Zeng

Junfen Cheng

Jian Huang

Affiliations

Soon will be listed here.

Abstract

Background: Lung cancer is an intractable disease and the second leading cause of cancer-related deaths and morbidity in the world. This study conducted a bioinformatics analysis to identify critical genes associated with poor prognosis in non-small cell lung cancer (NSCLC).

Methods: We downloaded three datasets (GSE33532, GSE27262, and GSE18842) from the gene expression omnibus (GEO), and used the GEO2R online tools to identify the differentially expressed genes (DEGs). We then used the Search Tool for Retrieval of Interacting Genes (STRING) database to establish a protein-protein interaction (PPI) network and used the Cytoscape software to perform a module analysis of the PPI network. A Kaplan-Meier plotter was used to perform the overall survival (OS) analysis, and the Gene Expression Profiling Interactive Analysis (GEPIA) database was used for expression level analysis of hub genes. Further, the UALCAN database was used to validate the relationship between the gene expression level of each hub gene and clinical characteristics.

Results: We identified 254 DEGs, which were composed of 66 up-regulated genes and 188 down-regulated genes. Out of these, five DEGs were identified as hub genes (CDC20, BUB1, CCNB2, CCNB1, UBE2C) by constructing a PPI network. The use of a Kaplan-Meier plotter to generate patient survival curves suggested a strong relationship between the five hub genes with worse OS. Validation of the above results using the GEPIA database showed that all the hub genes were highly expressed in NSCLC tissues. Using the UALACN data mining platform, we found that the five hub genes are correlated with tumor stage and the status of node metastasis in NSCLC patients.

Conclusions: We identified five hub DEGs that might provide perspectives in the explorations of pathogenesis and treatments for NSCLC.

Citing Articles

Key genes involved with prognosis were identified in lung adenocarcinoma by integrated bioinformatics analysis.

Song H, Wu J, Liu W, Cai K, Xie Z, Liu Y Heliyon. 2023; 9(6):e16789.

PMID: 37313154 PMC: 10258416. DOI: 10.1016/j.heliyon.2023.e16789.

Epigenetic regulation of stem cells in lung cancer oncogenesis and therapy resistance.

Wu J, Feng J, Zhang Q, He Y, Xu C, Wang C Front Genet. 2023; 14:1120815.

PMID: 37144123 PMC: 10151750. DOI: 10.3389/fgene.2023.1120815.

Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma.

Alghamdi R, Al-Zahrani M Saudi J Biol Sci. 2023; 30(4):103596.

PMID: 36879671 PMC: 9985037. DOI: 10.1016/j.sjbs.2023.103596.

Integrative Analysis for Identification of Therapeutic Targets and Prognostic Signatures in Non-Small Cell Lung Cancer.

Erkin O, Comertpay B, Gov E Bioinform Biol Insights. 2022; 16:11779322221088796.

PMID: 35422618 PMC: 9003654. DOI: 10.1177/11779322221088796.

Tumor mutation burden determined by a 645-cancer gene panel and compared with microsatellite instability and mismatch repair genes in colorectal cancer.

Zhou Z, Li K, Wei Q, Chen L, Shuai Y, Wang Y J Gastrointest Oncol. 2022; 12(6):2775-2787.

PMID: 35070406 PMC: 8748072. DOI: 10.21037/jgo-21-572.

References

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Klebig C, Korinth D, Meraldi P . Bub1 regulates chromosome segregation in a kinetochore-independent manner. J Cell Biol. 2009; 185(5):841-58. PMC: 2711590. DOI: 10.1083/jcb.200902128. View

Qian X, Song X, He Y, Yang Z, Sun T, Wang J . CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients. Biomed Pharmacother. 2015; 74:222-7. DOI: 10.1016/j.biopha.2015.08.004. View

Li N, Zeng Y, Huang J . Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer. J Cancer Res Clin Oncol. 2020; 146(6):1379-1393. DOI: 10.1007/s00432-020-03188-9. View

Davis S, Meltzer P . GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007; 23(14):1846-7. DOI: 10.1093/bioinformatics/btm254. View

Testa U, Castelli G, Pelosi E . Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells. Cancers (Basel). 2018; 10(8). PMC: 6116004. DOI: 10.3390/cancers10080248. View

Bidkhori G, Narimani Z, Ashtiani S, Moeini A, Nowzari-Dalini A, Masoudi-Nejad A . Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma. PLoS One. 2013; 8(7):e67552. PMC: 3708931. DOI: 10.1371/journal.pone.0067552. View

Huang H, Zhang Q, Ye C, Lv J, Liu X, Chen L . Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach. J Cancer Res Clin Oncol. 2017; 143(12):2571-2579. DOI: 10.1007/s00432-017-2497-0. View

Kim W, Jeong P, Yan C, Kim Y, Lee I, Kang H . UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria. Oncotarget. 2016; 7(36):58193-58202. PMC: 5295424. DOI: 10.18632/oncotarget.11277. View

10.

Zhang X, Zheng Q, Wang C, Zhou H, Jiang G, Miao Y . CCDC106 promotes non-small cell lung cancer cell proliferation. Oncotarget. 2017; 8(16):26662-26670. PMC: 5432287. DOI: 10.18632/oncotarget.15792. View

11.

Park S, Choi E, Bae D, Sohn H, Kim S, Kim Y . The LncRNA EPEL Promotes Lung Cancer Cell Proliferation Through E2F Target Activation. Cell Physiol Biochem. 2018; 45(3):1270-1283. DOI: 10.1159/000487460. View

12.

Mussnich P, Raverot G, Jaffrain-Rea M, Fraggetta F, Wierinckx A, Trouillas J . Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors. Cell Cycle. 2015; 14(16):2590-7. PMC: 4614981. DOI: 10.1080/15384101.2015.1064207. View

13.

Govindan R, Ding L, Griffith M, Subramanian J, Dees N, Kanchi K . Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell. 2012; 150(6):1121-34. PMC: 3656590. DOI: 10.1016/j.cell.2012.08.024. View

14.

Vargas A, Harris C . Biomarker development in the precision medicine era: lung cancer as a case study. Nat Rev Cancer. 2016; 16(8):525-37. PMC: 6662593. DOI: 10.1038/nrc.2016.56. View

15.

Liu G, Pei F, Yang F, Li L, Amin A, Liu S . Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer. Int J Mol Sci. 2017; 18(2). PMC: 5343902. DOI: 10.3390/ijms18020367. View

16.

von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B . STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003; 31(1):258-61. PMC: 165481. DOI: 10.1093/nar/gkg034. View

17.

Edgar R, Domrachev M, Lash A . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001; 30(1):207-10. PMC: 99122. DOI: 10.1093/nar/30.1.207. View

18.

Wan L, Tan M, Yang J, Inuzuka H, Dai X, Wu T . APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction. Dev Cell. 2014; 29(4):377-91. PMC: 4081014. DOI: 10.1016/j.devcel.2014.04.022. View

19.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

20.

Okamoto Y, Ozaki T, Miyazaki K, Aoyama M, Miyazaki M, Nakagawara A . UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res. 2003; 63(14):4167-73. View